Table 4.
Cohort | All samples | SCREEN-RA/SCQM | Rheuma-VOR | ||||||
---|---|---|---|---|---|---|---|---|---|
Patient group | FDR 1 | FDR 2 | FDR 3 | cRA | NRD | RA | PsA | axSpA | |
IgG response
P. gingivalis |
r = 0.268 | r = 0.223 | r = 0.220 | r = 0.041 | r = 0.376 | r = 0.444 | r = 0.181 | r = 0.417 | r = -0.027 |
P < 0.0001 (****) | P = 0.155 (ns) | P = 0.13 (ns) | P = 0.808 (ns) | P = 0.011 (*) | P < 0.01 (**) | P = 0.554 (ns) | P = 0.027 (*) | P = 0.946 (ns) | |
IgG response
P. intermedia |
r = 0.337 | r = 0.371 | r = 0.364 | r = 0.073 | r = 0.496 | r = 0.512 | r = 0.275 | r = 0.194 | r = 0.200 |
P < 0.0001 (****) | P = 0.016 (*) | P = 0.021 (*) | P = 0.665 (ns) | P < 0.001 (***) | P < 0.01 (**) | P = 0.363 (ns) | P = 0.321 (ns) | P = 0.557 (ns) | |
IgG response
P. melaninogenica |
r = 0.395 | r = 0.323 | r = 0.574 | r = 0.252 | r = 0.439 | r = 0.571 | r = 0.374 | r = 0.432 | r = 0.127 |
P < 0.0001 (****) | P = 0.037 (*) | P < 0.001 (***) | P = 0.127 (ns) | P < 0.01 (**) | P < 0.001 (***) | P = 0.21 (ns) | P = 0.022 (*) | P = 0.714 (ns) |